Safety of Programmed Death–1 Pathway Inhibitors Among Patients With Non–Small-Cell Lung Cancer and Preexisting Autoimmune Disorders

Giulia C. Leonardi, Mark M. Awad, Mehmet Altan et al.|Journal of Clinical Oncology|2018

Cited by 356